Work

First Cases of Allergic Contact Dermatitis From the New FreeStyle Libre 3 Sensor: Small Device, Multiple Allergens

Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Allergic contact dermatitis (ACD) from glucose sensors has become increasingly common. Newer devices, such as FreeStyle Libre 3 (Abbott Diabetes Care, UK), have been developed to enhance performance and reduce skin reactions. No ACD cases linked to this particular device have been reported to date. OBJECTIVE: To document the first cases of ACD linked to the FreeStyle Libre 3 sensor and to identify potential culprit allergenic components through patch testing and chemical analyses. METHODS: A retrospective chart review was conducted on 15 patients with suspected ACD related to the FreeStyle Libre 3 device who underwent patch testing at Antwerp University Hospital between November 2023 and November 2025. Chemical analyses of the device and associated adhesive components were performed using gas chromatography-mass spectrometry (GC-MS). RESULTS: Ten patients (67%) were diagnosed with ACD and most had prior exposure to other glucose sensors. The most frequent allergens were colophonium and related compounds, followed by (meth)acrylates, isocyanates and tert-butylphenol (TBP) derivatives. GC-MS analyses revealed the presence of most of these chemicals. CONCLUSIONS: Multiple newly identified as well as (modified) classic sensitizers contribute to ACD from the FreeStyle Libre 3 glucose sensor. Comprehensive ingredient disclosure and extended patch testing are essential for accurate diagnosis and prevention.
Language: English
Subfield: Dermatology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W7236039947
FWCI:
Cites: 44
Cited by:
Related to: 10